Table 3.
Indications for adjuvant therapy and rates of treatment (1989–1999).
| Indication | Age | Total | P value | ||
|---|---|---|---|---|---|
| 70–74 | 75–79 | ≥80 | |||
| Positive lymph nodes, number | 40 | 25 | 31 | 96 | NA |
|
| |||||
| Received chemotherapy, number (%) |
P ≤ 1 NS |
||||
| Yes | 22 (55) | 12 (48) | 11 (35) | 45 (47) | |
| No | 18 (45) | 13 (52) | 20 (64) | 51 (53) | |
|
| |||||
| Positive margins of resection, number | 47 | 27 | 44 | 113 | NA |
|
| |||||
| Received radiation therapy, number (%) |
P ≤ 0.05 S |
||||
| Yes | 42 (89) | 21 (78) | 30 (68) | 98 (87) | |
| No | 5 (11) | 6 (22) | 14 (32) | 25 (13) | |
|
| |||||
| Progesterone receptor positive, number (%) | 63 (42) | 32 (32) | 45 (32) | 140 | NA |
|
| |||||
| Estrogen receptor positive, number (%) | 69 (46) | 44 (43) | 58 (41) | 171 | NA |
|
| |||||
| Received hormonal therapy, number (%) |
P ≤ 1 NS |
||||
| Yes | 58 (84) | 38 (86) | 52 (90) | 148 (86) | |
| No | 11 (16) | 6 (14) | 6 (10) | 23 (14) | |
Abbreviation: NA: not applicable; NS: not significant; S: significant.